2023
DOI: 10.21203/rs.3.rs-2551241/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Efficacy and Safety of Pentoxifylline on Patients with Non-Alcoholic Steatohepatitis; Randomized Controlled Trial

Abstract: Background: Actually, no specific treatment has been endorsed by FDA for non-alcoholic steatohepatitis (NASH). The present research aimed to evaluate the efficacy of PTX on NASH patients for 6 months compared to NASH patients who received regular treatment. Methods: We assigned a 6-month, open-labeled, randomized study to 50 NASH participants who were allocated into 2 groups; firstly, the control group, patients administered regular therapy. Secondly, in the treated group, patients received regular treatment p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 67 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?